**Core Concept**
Tamoxifen is a selective estrogen receptor modulator (SERM) that plays a crucial role in the management of breast cancer, particularly in the treatment and prevention of estrogen receptor-positive (ER+) breast cancer. By binding to estrogen receptors, Tamoxifen blocks the action of estrogen on breast tissue, inhibiting the growth of ER+ breast cancer cells.

**Why the Correct Answer is Right**
Tamoxifen's mechanism of action involves binding to estrogen receptors (ER) on the surface of breast cancer cells. This binding prevents estrogen from binding to the receptors and activating downstream signaling pathways that promote cell growth and proliferation. By blocking estrogen's action, Tamoxifen reduces the risk of breast cancer recurrence and slows disease progression in patients with ER+ breast cancer. Additionally, Tamoxifen has been shown to have a beneficial effect on bone density and may reduce the risk of endometrial cancer.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Tamoxifen is not an aromatase inhibitor, which is a different class of medications used to reduce estrogen production in the body.
* **Option B:** This option is incorrect because Tamoxifen does not work by directly killing cancer cells, but rather by blocking the action of estrogen on breast tissue.
* **Option C:** This option is incorrect because while Tamoxifen may have some anti-androgen effects, its primary mechanism of action is through its estrogen receptor modulating activity.

**Clinical Pearl / High-Yield Fact**
Tamoxifen is the first-line treatment for hormone receptor-positive breast cancer in premenopausal women and is often used in combination with chemotherapy or radiation therapy.

**Correct Answer: C. Tamoxifen blocks the action of estrogen on breast tissue by binding to estrogen receptors, reducing the growth of estrogen receptor-positive breast cancer cells.**